Stereotaxis, Inc. (STXS): Total Assets

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$52.25M
As of 2025-12-31
$55.58M
As of 2026-06-30
-0.7%
3-year compound annual growth
-1.2%
5-year compound annual growth
+10.7%
10-year compound annual growth
$65.76M2010-12-31: $65.76M2011-12-31: $39.93M2012-12-31: $32.17M2013-12-31: $31.08M2014-12-31: $23.88M2015-12-31: $18.88M2016-12-31: $20.97M2017-12-31: $10.67M2018-12-31: $18.51M2019-12-31: $43.58M2020-12-31: $55.46M2021-12-31: $60.98M2022-12-31: $53.41M2023-12-31: $41.91M2024-12-31: $46.72M2025-12-31: $52.25M$52.25M
2010-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$52.25M+11.8%2026-03-12, Balance as of period end
2024-12-31$46.72M+11.5%2026-03-12, Balance as of period end
2023-12-31$41.91M-21.5%2025-03-14, Balance as of period end
2022-12-31$53.41M-12.4%2024-03-08, Balance as of period end
2021-12-31$60.98M+10.0%2023-03-09, Balance as of period end
2020-12-31$55.46M+27.2%2022-03-10, Balance as of period end
2019-12-31$43.58M+135.4%2021-03-12, Balance as of period end
2018-12-31$18.51M+73.6%2020-03-16, Balance as of period end
2017-12-31$10.67M-49.1%2019-03-15, Balance as of period end
2016-12-31$20.97M+11.1%2018-03-20, Balance as of period end
2015-12-31$18.88Mn/c2017-03-16, Balance as of period end
2014-12-31$23.88M-23.2%2016-03-11, Balance as of period end
2013-12-31$31.08M-3.4%2015-03-16, Balance as of period end
2012-12-31$32.17M-19.4%2014-03-27, Balance as of period end
2011-12-31$39.93M-39.3%2013-04-01, Balance as of period end
2010-12-31$65.76Mn/a2012-03-15, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Stereotaxis, Inc. (STXS)2025-12-31$52.25M+11.8%
electroCore, Inc. (ECOR)2025-12-31$18.67M-8.8%
Precision Optics Corporation, Inc. (POCI)2026-06-30$32.34M+63.4%
Iridex Corp (IRIX)2026-01-03$29.15M+0.1%
QT Imaging Holdings, Inc. (QTI)2025-12-31$23.02M+278.2%
Electromed, Inc. (ELMD)2026-06-30$66.27M+23.2%
Hyperfine, Inc. (HYPR)2025-12-31$55.26M-6.2%
CapsoVision, Inc (CV)2025-12-31$18.16M+8.1%
Escalon Medical Corp (ESMC)2026-06-30$9.13M+82.8%

Compare STXS, ECOR, POCI, IRIX side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗